1st Oct 2014 15:06
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc (GSK) was advised on 1 October 2014, that on 30 September 2014 the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.22 per Ordinary Share, and notional ADSs at a price of $46.31 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2014 to 30 September 2014:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent |
4,395.218 | |
Professor Sir Roy Anderson |
505.450 | |
Dr Stephanie Burns |
|
633.729 |
Stacey Cartwright |
373.594 | |
Lynn Elsenhans |
1,140.713 | |
Judy Lewent |
491.686 | |
Sir Deryck Maughan |
1,529.691 | |
Dr Daniel Podolsky |
1,147.268 | |
Tom de Swaan |
461.498 | |
Jing Ulrich |
316.865 | |
Hans Wijers |
373.594 |
V A Whyte
Company Secretary
1 October 2014
Related Shares:
Glaxosmithkline